Skip to content

Live5.News

  • South Carolina
  • USA
  • World
  • Tech
  • Business
  • Sports
  • Entertain
  • Health
Live5.News

Live5.News

  • South Carolina
  • USA
  • World
  • Tech
  • Business
  • Sports
  • Entertain
  • Health

OXFORD UNIVERSITY

AstraZeneca may have “included outdated information” in the COVID-19 vaccine trial report, says the US

AstraZeneca may have “included outdated information” in the COVID-19 vaccine trial report, says the US

AstraZeneca’s Covid-19 vaccine is safe, 79% effective in end-stage tests in the USA

AstraZeneca’s Covid-19 vaccine is safe, 79% effective in end-stage tests in the USA

AstraZeneca (AZN) -Oxford Vaccine Prevents 79% of Covid Cases, US Data Show

AstraZeneca (AZN) -Oxford Vaccine Prevents 79% of Covid Cases, US Data Show

AstraZeneca Covid Vaccine India Delay in shipment due to cut in supply in the UK, the source said

AstraZeneca Covid Vaccine India Delay in shipment due to cut in supply in the UK, the source said

Oxford-AstraZeneca Covid-19 Vaccine Startup in conflict with the university before the planned IPO

Oxford-AstraZeneca Covid-19 Vaccine Startup in conflict with the university before the planned IPO

India’s launch of the Covid-19 vaccine ‘rescued the world’ from the pandemic, says a leading US scientist

India’s launch of the Covid-19 vaccine ‘rescued the world’ from the pandemic, says a leading US scientist

One of the strongest weapons against COVID-19 variants may be a vaccine that the FDA has not yet approved

One of the strongest weapons against COVID-19 variants may be a vaccine that the FDA has not yet approved

Vacid-19 ‘Passports’ raise ethical issues and logistical obstacles

Vacid-19 ‘Passports’ raise ethical issues and logistical obstacles

The 3-month interval between Oxford jabs ensures greater effectiveness: Study |  India News

The 3-month interval between Oxford jabs ensures greater effectiveness: Study | India News

One of the strongest weapons against COVID-19 variants may be a vaccine that the FDA has not yet approved

Oxford University starts COVID-19 vaccine trial in children aged 6 to 17

Oxford University adds children to the study AstraZeneca COVID-19

Oxford University adds children to the study AstraZeneca COVID-19

One of the strongest weapons against COVID-19 variants may be a vaccine that the FDA has not yet approved

Oxford University starts COVID-19 vaccine trial in children aged 6 to 17

Older posts
Page1 Page2 Page3 Next →

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Live5.News